Brief: Karyopharm Therapeutics Q3 Net Income USD -34.506 Million
Nov 02 (Reuters) - Karyopharm Therapeutics Q3 operating income USD -31.26 million. * Q3 operating expenses USD 67.269 million * Q3 product revenue USD 30.207 million * outlook FY revenue USD 145-160 million